Quality of Life in Patients with Bronchial Asthma in Childhood
Authors: Anna Todorova, Antoaneta Tsvetkova, Ana-Maria Velcheva, Maia Radeva, Kristina Decheva, Teodora Georgieva, Nadia Agova
Number of views: 583
Bronchial asthma is a major cause of morbidity in children in developed countries. In recent years, a large number of epidemiological studies have found an in- creased incidence of childhood asthma which makes this respiratory disorder the most frequent chronic dis- ease in childhood. Many factors are responsible for the huge incidence of asthma: triggering factors from the external environment, the use of inappropriate an- ti-inflammatory medication, lack of assistance with regard to therapeutic regimen, inadequate training of patient (family). The quality of life adolescents suffer- ing of bronchial asthma and their families often is ex- tremely deteriorated. Asthma may limit the ability of children to play, learn and sleep, to lead normal active life. Achieving disease control is the main goal of the treatment conducted. The Global initiative for asthma (GINA) defines control on asthma as minimal chron- ic symptoms, no emergency medical visits, no need of saving medication, normal daily activity, social adap- tation and school attendance.
The aim of this study is to analyze the quality of life of children with asthma based on the achieved disease control. To achieve this goal a survey was conducted among parents and children of various ages in the city of Varna. Data from the surveys were processed using mathematical and statistical methods, and the results are presented by graphic images.
Results show that in early childhood, when the treatment is performed under the supervision of par- ents, a well-controlled treatment is achieved compared to teenage years.
Bronchial asthma is a chronic disease that is best affected in “therapeutic cooperation” between clini- cians, patients and their families. Implementation of training programs for children and parents will im- prove their compliance and execution of their indi- vidual treatment plan, and hence disease control and quality of life of patients.